CAS 209799-75-7

4H-Pyrrolo[3,2-d]pyrimidin-4-one,2-amino-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-3,5-dihydro-

Description:

4H-Pyrrolo[3,2-d]pyrimidin-4-one, 2-amino-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-3,5-dihydro- is a complex organic compound characterized by its unique bicyclic structure, which includes a pyrrolo and pyrimidinone moiety. This compound features multiple functional groups, including amino and hydroxyl groups, contributing to its potential biological activity. The presence of stereocenters in the pyrrolidine ring indicates chirality, which can influence its pharmacological properties. Typically, compounds of this nature are investigated for their roles in medicinal chemistry, particularly in the development of pharmaceuticals targeting various biological pathways. The molecular interactions, solubility, and stability of this compound can be influenced by its structural features, making it a subject of interest in drug design and synthesis. Its CAS number, 209799-75-7, allows for precise identification in chemical databases, facilitating research and development efforts in both academic and industrial settings.

Formula: C₁₁H₁₅N₅O₄

Synonyms:

• 4H-Pyrrolo[3,2-d]pyrimidin-4-one,2-amino-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1,5-dihydro-(9CI)
• Immucillin G

Immucillin-G

Controlled Product

CAS: 209799-75-7

Formula: C₁₁H₁₅N₅O₄

Color and Shape: Neat

Molecular weight: 281.268

Ref: TR-I490003

1-(9-Deazaguanin-9-yl)-1,4-dideoxy-1,4-iminoribitol

CAS: 209799-75-7

1-(9-Deazaguanin-9-yl)-1,4-dideoxy-1,4-iminoribitol is an analog of mannitol that acts as a potent inhibitor of kinase activity. It has been shown to induce apoptosis in cancer cells and has potential as an anticancer agent. This compound inhibits the activity of Chinese hamster ovary cell kinases and luciferase kinases, which are involved in protein synthesis and tumor growth. Additionally, this compound has been found in human urine samples, suggesting that it may have clinical relevance as a therapeutic agent for cancer treatment. Overall, 1-(9-Deazaguanin-9-yl)-1,4-dideoxy-1,4-iminoribitol shows great promise as a novel inhibitor with potential for use in cancer therapy.

Formula: C₁₁H₁₅N₅O₄

Purity: Min. 95%

Molecular weight: 281.27 g/mol

Ref: 3D-JIA79975